EORTC-20991-LYMG

Diffuse large B cell and peripheral T cell non-Hodgkin's lymphomas in the elderly. Influence of prolonged oral etoposide added to CHOP combination chemotherapy in patients with good physiological status. An EORTC phase II-III trial including geriatric assessment and quality of life.
Study documentation
Trial StatusAll trial activities ended
DatesDate of activation: 19-Mar-03
Closed on : 13-Aug-04
Data management at EORTCFull
Phase2-3
Randomized trialYes
TypeHemato-malign
Targeted Sample size126
Number of steps1
DrugCyclophosphamide
Doxorubicin
Vincristine
Study Staff
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00060385
EudraCT